T cells from patients with Candida sepsis display a suppressive immunophenotype
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Despite appropriate therapy, Candida bloodstream infections are associated with a mortality rate of approximately 40 %. In animal models, impaired immunity due to T cell exhaustion has been implicated in fungal sepsis mortality. The purpose of this study was to determine potential mechanisms of fungal-induced immunosuppression via immunophenotyping of circulating T lymphocytes from patients with microbiologically documented Candida bloodstream infections. Methods: Patients with blood cultures positive for any Candida species were studied. Non-septic critically ill patients with no evidence of bacterial or fungal infection were controls. T cells were analyzed via flow cytometry for cellular activation and for expression of positive and negative co-stimulatory molecules. Both the percentages of cells expressing particular immunophenotypic markers as well as the geometric mean fluorescence intensity (GMFI), a measure of expression of the number of receptors or ligands per cell, were quantitated. Results: Twenty-seven patients with Candida bloodstream infections and 16 control patients were studied. Compared to control patients, CD8 T cells from patients with Candidemia had evidence of cellular activation as indicated by increased CD69 expression while CD4 T cells had decreased expression of the major positive co-stimulatory molecule CD28. CD4 and CD8 T cells from patients with Candidemia expressed markers typical of T cell exhaustion as indicated by either increased percentages of or increased MFI for programmed cell death 1 (PD-1) or its ligand (PD-L1). Conclusions: Circulating immune effector cells from patients with Candidemia display an immunophenotype consistent with immunosuppression as evidenced by T cell exhaustion and concomitant downregulation of positive co-stimulatory molecules. These findings may help explain why patients with fungal sepsis have a high mortality despite appropriate antifungal therapy. Development of immunoadjuvants that reverse T cell exhaustion and boost host immunity may offer one way to improve outcome in this highly lethal disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 5×
“Conclusions The incidence of Candida bloodstream infection is increasing and Candida is currently one of the most common nosocomial bloodstream infections in many intensive care units (ICUs) [1, 2, 4, 5, 20, 21].”
BackgroundResultInfluentialWherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 3×
“Although there were no differences in BTLA, TIM-3, or 2B4, other markers of T cell exhaustion, in patients with Candida bloodstream infection versus controls, cellular expression of these markers is not as frequently abnormal as expression of PD-1 or PD-L1 in T cell exhaustion [14].”
BackgroundMethodMultistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 3×
“Estimates suggest that there are between 7,000 and 28,000 nosocomial Candida bloodstream infections per year, leading to 2,800 and 11,200 deaths per year in the United States [4, 6, 7].”
BackgroundSepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772 · cited 1×
“This hypothesis is supported by studies of interleukin-7 (IL-7), a pleiotropic cytokine that enhances T cell function [10, 32–35].”
MethodSelf-citationEpidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376
Aging of the T Cell Compartment in Mice and Humans: From No Naive Expectations to Foggy Memories
Nikolich-Žugich, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401174 · Cited by 259 · cited 1×
“Many of these patients are elderly individuals whose immune system is impaired due to “immunosenescence” [31].”
BackgroundFungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62 · cited 1×
“Conclusions The incidence of Candida bloodstream infection is increasing and Candida is currently one of the most common nosocomial bloodstream infections in many intensive care units (ICUs) [1, 2, 4, 5, 20, 21].”
BackgroundZhu, X., & Niedermann, G. (2015) · Oncoscience · doi:10.18632/oncoscience.164 · Cited by 15 · cited 1×
“These molecules included CD69, an early activation marker, CD28, a key positive co-stimulatory molecule, IL-7 receptor (IL-7R), which is decreased in exhausted T cells, the negative co-stimulatory molecules T cell immunoglobulin domain and mucin domain 3 (TIM-3) and B and T lymphocyte attenuator (BTLA), and CD57 which…”
Background
Cited by
Advances in the understanding and treatment of sepsis-induced immunosuppression
Venet, F., & Monneret, G. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.165 · Cited by 981
The immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition
Sattler, A., Angermair, S., Stockmann, H., Heim, K. M., Khadzhynov, D., Treskatsch, S., Halleck, F., Kreis, M. E., & Kotsch, K. (2020) · Journal of Clinical Investigation · doi:10.1172/jci140965 · Cited by 196
Roles of BTLA in Immunity and Immune Disorders
Ning, Z., Liu, K., & Xiong, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654960 · Cited by 157
“reported that differences in BTLA levels in CD4 and CD8 T cells were not statistically significant between patients with Candida sepsis and controls (73).”
BackgroundHuggins, M. A., Sjaastad, F. V., Pierson, M., Kucaba, T. A., Swanson, W., Staley, C., Weingarden, A. R., Jensen, I. J., Danahy, D. B., Badovinac, V. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.028 · Cited by 114
Metadata
- Authors
- Spec, A., Shindo, Y., Burnham, C.-A. D., Wilson, S., Ablordeppey, E. A., Beiter, E. R., Chang, K., Drewry, A. M., & Hotchkiss, R. S.
- Venue
- Critical Care
- Published
- 2016-01-20
- Volume
- 20
- Issue
- 1
- Pages
- 15-15
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2257863643
- Cited by
- 128
- References
- 9
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: T cells from patients with Candida sepsis display a suppressive immunophenotype. https://app.cochat.ai/papers/10.1186/s13054-016-1182-z
- The paper
- Spec, A., Shindo, Y., Burnham, C.-A. D., Wilson, S., Ablordeppey, E. A., Beiter, E. R., Chang, K., Drewry, A. M., & Hotchkiss, R. S. (2016). T cells from patients with Candida sepsis display a suppressive immunophenotype. Critical Care. https://doi.org/10.1186/s13054-016-1182-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.